Cytokines have significant roles in some cardiovascular disorders, but direct myocardial effects of cytokines remain to be elucidated. In the present study, we examined both the early and delayed effects of interleukin-6 (IL-6) on cultured chick embryo ventricular myocytes. Exposure of these cells to human recombinant IL-6 significantly decreased peak systolic [Ca2+]i (71.0+0.6% of the control value) and the amplitude of cell contraction (66.0±7.4% of the control value) within a few minutes. Pretreatment with N0-monomethyl-L-arginine (L-NMMA) or methylene blue completely inhibited the IL-6induced early changes. Subsequent addition of L-arginine reversed the effects of L-NMMA. The levels of cGMP were significantly increased after 30 minutes of exposure to IL-6 (134.4+9.1% of the control value). Pretreatment with L-NMMA or EGTA significantly inhibited the IL-6-induced early elevation of cGMP. These results suggest that IL-6 acutely decreases intracellular Ca 2 transients and depresses cell con-traction by nitric oxide (NO)-cGMP-mediated pathway. Therefore, IL-6 may enhance the Ca'+-dependent constitutive NO synthase activity in cardiac myocytes. On the other hand, 24-hour exposure to IL-6 also increased the levels of cGMP (159.0±22.8% of the control value) regardless of pretreatment with EGTA. These delayed increases in cGMP were also shown to be coupled with decreases in intracellular Ca 2+ transients and the amplitude of cell contraction. Thus, IL-6 may induce Ca2-independent NO synthase in cardiac myocytes. Together with the previous reports that have suggested the possible roles of IL-6 in myocardial stunning or endotoxic shock, this negative inotropic effect of IL-6 may contribute to these clinical settings. (Circ Res. 1994;75:285-295.) 
In response to tissue injury, proinflammatory cytokines are produced by infiltrating cells or preexisting cells. Myocardial injury results from various causes, including ischemia, allograft rejection, autoimmune diseases, and infection. The roles of cytokines in these myocardial disorders have not been definitely determined, but some reports have supported that cytokines play a crucial role in myocarditis,' graft rejection,2 acute myocardial infarction,3 and reperfusion injury.4 '5 In those studies, immunologic aspects of cytokines have come to light, but their direct physiological effects on myocardium have not been fully understood. Interleukin 6 (IL-6), one of these cytokines, has pleiotropic activities.6,7 From the clinical point of view, overproduction of IL-6 has been reported in patients with inflammatory disorders, such as collagen diseases. 7 Increased levels of IL-6 in serum have also been demonstrated in acute myocardial infarction3 and cardiac myxoma. 8 Especially in cardiac myxoma, tumorproduced IL-6 is a major determinant of the clinical manifestations of the disease.8 In spite of its variety of biological actions, cardiovascular effects of IL-6 have not been fully elucidated,9 but a couple of reports support the hypothesis that IL-6 may act as a cardiac depressant in some conditions. One of these conditions is a "stunned myocardium,"'10"' which is defined as a transient depression of myocardial contractility accompanied by reperfusion after brief ischemia.12 Increased production of cytokines during the ischemia/reperfusion state has been reported,4'5 suggesting that IL-6 may also contribute to myocardial stunning. On the other hand, myocardial depression may occur during endotoxic shock. 13 It is well known that endotoxemia frequently results in so-called "warm shock," which is characterized by decreased systemic vascular resistance. During the warm shock, myocardial function is considered to be conserved,9 but the decreased afterload may mask depressed myocardial contractility. In endotoxemia, the serum levels of IL-6 as well as other cytokines have also been shown to be elevated,14 and IL-6 may act as a cardiac depressant.
Recently, intracellular signaling pathways of cytokine actions have been investigated, and some of them have been reported to be via nitric oxide (NO), which is produced by NO synthase (NOS). [15] [16] [17] [18] Cytokines in macrophages induce NOS (MacNOS19) and produce NO through conversion from arginine to citrulline. 18 The produced NO reacts with metals and creates the redox form of NO, which has a cytotoxic effect on target cells,'6 such as parasites18 and tumor cells. 20 In many other cells, cytokines can also induce NOS through gene induction.2' On the other hand, in endothelial cells and neuronal cells, constitutively expressed NOS (ECNOS22 and BNOS,23 respectively) produces NO that is dependent on Ca>2calmodulin activation and subsequently increases the intracellular level of cGMP. '15'7 The increased cGMP causes vasodilation in vascular smooth muscle cells or mediates neurotransmission among neuronal cells. '5,17 Recent studies demonstrated that cytokines had a negative inotropic effect on myocardium and that this effect might be mediated by NO production.10'3 However, changes in other intracellular signals, particularly intracellular Ca 2+, a major player in myocardial excitation-contraction coupling, have not been well recognized. Accordingly, the objective of the present study was to clarify the effects of IL-6 on Ca2' handling and cell contraction in cultured chick ventricular myocytes. We also investigated whether the effects of IL-6 on myocardial Ca>2 handling were mediated by NO.
Materials and Methods Chick Embryonic Ventricular Myocyte Culture
Ventricular myocytes were cultured from 10-day-old chick embryos with modification of the previously described methods. 24 In brief, ventricles from 10-day-old chick embryos were minced and placed in Ca'and Mg`2-free Hanks' balanced salt solution with 0.25% trypsin at 37C for four cycles of 8 minutes each. The supernatant was discarded, and the cells were resuspended in culture medium consisting of 6% fetal calf serum, 40% medium 199, 0.1% penicillin-streptomycin solution, and 54% balanced salt solution containing (mmol/L) NaCl 116, NaH2PO4 1.0, MgSO4 0.8, NaHCO3 26.2, CaCl2 0.9, and glucose 5. The cell suspension was diluted to 1X106 cells per milliliter and placed in plastic Petri dishes or 24-well culture plates. The cells were incubated in 5% CO2 atmosphere for 2 days at 37°C. On day 3, culture media were exchanged for serum-free media consisting of 20% medium 199, 20% F-12 Ham, 0.1% penicillin-streptomycin solution, 54% balanced salt solution, 0.6 mmol/L KCl, and 5 ng/mL insulin-transferrin-selenium mixture. All experiments were performed at least 2 days after the exchange of the culture media. At that time, cells were grown almost to confluence.
Simultaneous Measurements of [Ca"2]i and

Cell Contraction
[Ca>]i was measured with the Ca 2+ fluorescent dye indo 1 as previously described.24'25 Loading stock of 100 ,umol/L indo 1 acetoxymethyl ester (indo 1-AM) was prepared by sonication and consisted of 8.79 mL fetal calf serum, 210 ,L of 25% Pluronic F127 (wt/wt in dimethyl sulfoxide), and 1 mL of 1 mmol/L indo 1-AM in dimethyl sulfoxide. The loading stock was diluted in the culture medium up to 5 ,umol/L of indo 1-AM concentration. Coverslips of the cultured chick ventricular myocytes were incubated at 37°C in the diluted dye solution for 15 minutes and then washed in indo 1-free culture media for 10 minutes. After the dye loading, a coverslip was placed in a flow-through chamber, which was equipped with a clear glass bottom and mounted on the stage of an inverted microscope (Nikon Diaphot). The cells were continuously superfused at 37°C with HEPES-buffered physiological solution containing (mmol/L) NaCl 137, KCl 3.7, MgCl2 0.5, CaCl2 1.8, glucose 5.6, and HEPES 4.0 (pH 7.35) . The instrumentation used for fluorescence measurement has been described previously.24 In brief, a high-pressure mercury arc lamp was used as the excitation light source, which provided an intense peak at 360 nm. The cells were illuminated via epifluorescence optics using a Fluor x40 objective lens (Nikon Diaphot). The fluorescent light was collected by the objective lens and divided with a dichroic mirror system (Rincon Scientific) to permit simultaneous measurement of both 400-and 500-nm wavelengths by use of two separate photomultiplier tubes. The ratio of emitted fluorescence (400/500) was obtained on-line through an analog-divider circuit. By the "in vitro" calibration method as described previously, 24 [Ca>2]i was calculated from the 400/500 (nm) fluorescence ratio (R) as follows: [Ca2]i (nmol/L) =250x (R-Rmin)/(Rmax-R) X 3. Cell contraction was measured by means of a video motion detector with plastic microspheres (Latex beads, obtained from Sigma Chemical Co) attached to the surface of a layer of the cultured myocytes. 24, 25 [Ca 2+]i and the amplitude of cell contraction were collected from an average of five consecutive beats. Peak systolic [Ca2+] of the control beat was arbitrarily set as 100% for normalization of the following intracellular Ca 2+ transients. For normalization of the cell contraction, the amplitude of control beat was set as 100%.24,25 End-diastolic cell position was quantified as percent shift length over the amplitude of the control beat as described previously.25
Two-Dimensional Image Analyses of [Ca2"]i
To obtain two-dimensional images of [Ca2+]i,26 cells on a coverslip were loaded with 10 gmol/L indo 1-AM as described above. The fluorescence measurement was performed by means of the same instrumentation described above except for an image-intensified CCD camera (Hamamatsu Photonics) instead of photomultiplier tubes. The fluorescent image collected by the CCD camera was fed to a computed analyzing system (ARGUS-50, Hamamatsu Photonics). Fluorescence ratios were obtained by dividing pixel by pixel (the 405-nm image after background subtraction by the 480-nm image after background subtraction). The ratio images were visualized with color gradient. To distinguish the margin of each cell in the two-dimensional images, cells were plated at a lower concentration, ie, 2 x 10 cells per milliliter.
cGMP Assay Chick ventricular myocytes were cultured in 24-well culture plates. Cell numbers were determined by a Coulter counter, and for this experiment, '5 x 105 cells were plated per well. Protein content measured by Lowry's method27 was :250 utg per well. Culture media were exchanged for the fresh serumfree media with or without the drugs for pretreatment, and then cells were incubated at 37°C in 5% CO2 for at least 10 minutes before intervention. After the incubation of predetermined periods, cells were washed twice with Ca2+and Mg 2+ free phosphate-buffered saline and harvested in 1 mL of 6% trichloroacetic acid. Aliquots were then homogenized at 4°C and stored at -20C until use. cGMP content was measured by radioimmunoassay with a cGMP assay kit following the manufacturer's instructions.28 Briefly, 20 ,uL of each homogenized aliquot was succinylated, mixed with '251-succinyl cGMP tyrosine methyl ester and anti-cGMP monoclonal antibody, and placed on ice for 24 to 48 hours. A standard reaction curve was drawn on every experiment. Each sample was duplicated, and the mean values were collected. For normalization of cGMP content, the content of the control group was set as 100%.
Study Protocols
To examine the acute effects on [Ca 2+], and cell contraction, myocytes were superfused with vehicle or IL-6. Stock solutions of IL-6 were prepared as follows: lyophilized human recombinant IL-6 was dissolved in Ca2+and Mg 2+-free phosphatebuffered saline containing 0.1% bovine serum albumin, and these aliquots were stored at -80°C. The recombinant IL-6 of 1 ng is approximately equivalent to 1000 U. On measurements of [Ca>2], and cell contraction, HEPES-buffered physiological solutions containing NG-monomethyl-L-arginine (L-NMMA), IL-6, L-arginine, and/or methylene blue were superfused. IL-6 1,000 unit/mi solutions containing L-arginine. Perfusion with L-arginine was always performed in L-NMMA-pretreated cells in order to substitute for L-NMMA. In this condition, data were collected 2 minutes after perfusion with L-arginine solution.
In our fluorescence microscopy system, it is difficult to observe [Ca 2+]i and cell contraction continuously for hours. It is also difficult to compare [Ca2>i and cell contraction between cells on two different coverslips. Therefore, to test whether hours of exposure to IL-6 cause changes in [Ca2+]i and cell contraction via NO-cGMP-mediated pathways, responses to L-arginine of L-NMMA-pretreated cells were examined. Cultured cells on coverslips were pretreated with L-NMMA (10 ,mol/L) for 10 minutes, and then IL-6 (1000 U/mL) was added. After incubation for 6 or 24 hours at 37°C in 5% C02, cells were loaded with indo 1-AM as in the above-described method, except that both the loading and washing solutions contained 10 ,umol/L L-NMMA. After the dye loading, HEPES-buffered solution containing L-NMMA (10 ,umol/L) was first superfused, and then the perfusion with 10 mmol/L L-arginine was tested.
[Ca21]i and the amplitude of cell contraction were also normalized by control values as described above. For characterization of cell types, effects of 100 nmol/L angiotensin II and 1 ,umol/L bradykinin were examined in the verapamil-pretreated cells. Exposure to verapamil (1 gmol/L) completely arrested the spontaneous beating of cultured cardiac myocytes. Effects of angiotensin II and bradykinin were observed by means of intracellular Ca 2+ transients and twodimensional image analyses of [Ca 2+]i.
In the cGMP assay, cultured myocytes were pretreated with the serum-free media with or without L-NMMA or EGTA for 10 minutes at 37°C in 5% C02, and then IL-6 was added. In the case of pretreatment with dexamethasone, cultured myocytes were incubated in the serum-free media with or without dexamethasone for 30 minutes, and subsequently, IL-6 was added. The reaction was terminated by the addition of 1 mL of 6% trichloroacetic acid.
Materials
Fetal calf serum, medium 199, penicillin-streptomycin solution, F-12 Ham, and bovine serum albumin were obtained from GIBCO Laboratories. Insulin-transferrin-selenium mixture, L-NMMA, L-arginine, methylene blue, dexamethasone, sodium nitroprusside, angiotensin II, and bradykinin were purchased from Sigma Chemical Co. Indo 1-AM was from Dojin Kagaku. Pluronic F127 was from BASF. The cGMP assay kit was obtained from YAMASA Shoyu K.K. IL-6 was from Takara Syuzoh. Verapamil HCI was a generous gift from Eisai Co.
Statistics
Values are expressed as mean+± SEM. Differences in the data among the groups were tested by two-way ANOVA. If the F test showed an overall significance, comparison of the two groups was performed by the paired t test with the Bonferroni correction.29 Values of P<.05 were considered to be statistically significant.
Results
IL-6 Acutely Causes a Negative Inotropic Effect and Decreases [Ca 2+1i
Fig 1 exhibits representative tracings of intracellular Ca 2+ transients and cell contraction before and after the addition of 1000 U/mL human recombinant IL-6 to the spontaneously beating cultured chick embryo ventricular myocytes. As shown in this figure, IL-6 of 1000 U/mL decreased peak systolic [Ca2+]i (71.0±0.6% of the control value, P<.01, n=5) and the amplitude of cell contraction (66.0±7.4% of the control value, P<.01, n=5) in the cardiac myocytes within a few minutes. These effects persisted throughout the IL-6 perfusion. End-diastolic cell position shifted downward after perfusion with 1000 U/mL IL-6 (-17.9±2.1%, P<.01, n=5). This may suggest that IL-6 decreases the Ca21 sensitivity of contractile proteins. The spontaneous beating rate was significantly increased by exposure to IL-6 (from 96±11 to 145±20 beats per minute, P<.05, n=5). Dose-response graphs of these IL-6 effects are shown in Ca2l transients and cell contraction.
When pretreated with 10 ,umol/L NGmonomethyl-L-arginine (L-NMMA), the cultured ventricular myocytes did not 200 show significant changes in intracellular Ca2l transients or cell contraction after 115 exposure to 1000 U/mL interleukin-6 (IL-6) (A). Relative increases in beating rate were observed after addition of IL-6, even after pretreatment with L-NMMA. A subsequent addition of 10 mmol/L L-arginine (L-Arg) caused significant decreases in peak systolic [Ca2+]j and cell contraction (B). End-diastolic cell position shifted downward after addition of L-Arg. However, addition of L-Arg after IL-6 exposure in the cells not pretreated with L-NMMA did not enhance the IL-6induced [Ca2+]i-lowering effect or negative inotropism (C). Methylene blue (MB, 10 gmol/L) itself did not affect intracellular Ca21 transients and cell contraction, 3 and IL-6 did not cause any significant effect on cardiac myocytes after pretreat-308 ment with MB (D). Spontaneous beating also became faster after exposure to IL-6 -115 in the presence of MB. Transients and Cell Contraction Are Mediated by NO-cGMP Pathways Exposure to 10 ,mol/L L-NMMA, an analogue of L-arginine and a potent inhibitor of NO production, itself did not significantly alter intracellular Ca2' transients ( Fig 3A) or the amplitude of cell contraction ( Fig 3B) . After pretreatment with 10 ,umol/L L-NMMA, exposure to 1000 U/mL IL-6 did not cause any significant changes in intracellular Ca2' transients ( Fig 3A) or cell contraction ( Fig 3B) . Further addition of 10 mmol/L L-arginine, a precursor of NO, restored the effects of IL-6, ie, significantly decreased peak systolic [Ca 2+]i ( Fig 3A) and the amplitude of cell contraction ( Fig 3B) . End-diastolic cell position shifted downward (-25.2±3.6%, P<.01, n=4) after the addition of L-arginine, which might indicate that NO decreased the Ca 2+ sensitivity of the contractile protein. These data suggest that these effects of IL-6 might be mediated by NO production. As to beating rate, exposure to IL-6 after pretreatment with L-NMMA induced relative increases in the spontaneous beating rate (from 111±1 to 136±7 beats per minute, P<.05 versus control, n=4), although L-NMMA itself did not change the beating rate (from 111±1 to 114±4 beats per minute, n=4). Representative tracings of the sequential interventions are shown in Fig 4A and 4B .
Besides, the addition of L-arginine (10 mmol/L) after exposure to IL-6 (1000 U/mL) did not enhance the IL-6-induced decreases in either peak systolic [Ca2"] (from 76.5±2.2% to 74.4±1.0% of the control value, n=3) or the amplitude of cell contraction (from 64.7±2.8% to 67.2±0.5% of the control value, n=3) in the cells not pretreated with L-NMMA. Additional L-arginine did not affect the IL-6-evoked downward shift of end-diastolic cell position (from -17.6±8.2% to -16.4±7.7%, n=3). Representative tracings are shown in Fig 4C. This may suggest that sufficient substrate for NOS already exists in the cytoplasm of cardiac myocytes stimulated with IL-6.
Exposure to 10 ,umol/L methylene blue, an inhibitor of soluble guanylate cyclase, itself did not change intracellular Ca21 transients ( Fig SA) or cell contraction ( Fig   5B) . After pretreatment with methylene blue (10 ,umol/ L), exposure to IL-6 (1000 U/mL) did not cause any significant effect on intracellular Ca21 transients ( Fig  SA) or cell contraction ( Fig SB) . Thus, these IL-6induced effects appeared to be mediated by increased cGMP production. With regard to beating rate, pretreatment with methylene blue did not cause any change (from 106±5 to 110±2 beats per minute, n=3), but the addition of IL-6 significantly increased the spontaneous beating rate (from 106±5 to 127±4 beats per minute, P<.01 versus the control value, n=3). Representative tracings are shown in Fig 4D . Increases in [Ca2"]i by angiotensin II exposure were not observed in any cells, which was also confirmed by intracellular Ca> transients during the same intervention ( Fig 6E) . Vascular smooth muscle cells or fibroblasts have inositol trisphosphate-sensitive Ca2+ stores, and in these cells, angiotensin II increases [Ca>], even after pretreatment with L-type Ca> channel blocker.30
Therefore, our primary culture appeared to contain a negligible amount of vascular smooth muscle cells or fibroblasts. We also examined the effects of bradykinin (1 ,umol/L) after pretreatment with verapamil (1 1,mol/L) by two-dimensional imaging of [Ca>]i ( Fig 6D) and intracellular Ca> transients (Fig 6F) . Bradykinin has been known to increase [Ca>]i in endothelial cells by releasing Ca' from the intracellular store or by increasing Ca' influx via nonselective cation channels. 31 Fig 6D and 6F show that increases in [Ca>]i after bradykinin exposure were not observed in any cells, which implies that our primary culture did not contain any functionally active endothelial cells. cGMP Content Is Increased After IL-6 Exposure in a Biphasic Manner for the intracellular Ca2+ transients and cell contraction, IL-6 of >500 U/mL caused an almost saturated effect on the initial increase in cGMP. This initial increase in cGMP was inhibited by pretreatment with 10 ,umol/L L-NMMA or 1 mmol/L EGTA (Table 1 ). These results suggest that the initial increase in cGMP after IL-6 exposure was induced by NO dependent of Ca`. Sodium nitroprusside (5 ,umol/L), an NO-generating agent, significantly increased cGMP content (151.1±12.7% of the control value, P<.05, n=3), and pretreatment with EGTA (1 mmol/L) did not attenuate this increase in cGMP (156.8±17.0% of the EGTA-treated control value, P<.05, n=3). Thus, the activity of soluble guanylate cyclase in cardiac myocytes does not appear to be affected by EGTA treatment, at least when stimulated with NO. These data are consistent with a previous report.33 Hence, it seems that the inhibition by EGTA of the initial increase in cGMP after IL-6 exposure was not a consequence of inhibition of soluble guanylate cyclase itself but a result of the inhibition of Ca2+-dependent constitutive NOS in cardiac myocytes. Fig 7A also shows that exposure to IL-6 for 24 hours reenhanced cGMP production (159.0±22.8% of the control value, P<.05, n=3). In contrast to the initial increase in cGMP, this delayed increase was inhibited by L-NMMA and dexamethasone but not by EGTA ( Table 2 ). These data suggest that the delayed increase in cGMP was mediated by NO independent of Ca>.
IL-6 Attenuates Cell Contraction and [Ca"], Through Induction of NOS
According to the cGMP assay, exposure to IL-6 for 24 hours appeared to induce NOS, but the increases in cGMP were significantly inhibited in the presence of L-NMMA. When L-arginine was substituted for L-NMMA, the induced NOS might be supplied with its substrate and generate both NO and cGMP. In this regard, we can test the function of the inducible NOS. . When HEPES-buffered solution was perfused, >95% of the cells were spontaneously beating. Panel A shows images of peak systole and end diastole. As shown in the two images, [Ca2+], in almost all the cells was changed, synchronizing with the beating cycle. Thus, >95% of the cultured cells were considered to be beating cardiac myocytes. The points of peak systole and end diastole were determined by intracellular Ca2+ transients (calculated by ARGUS) of the same cells (graph, B). In this case, peak systole and end diastole were the points of 667 milliseconds (indicated by double arrow) and 484 milliseconds (indicated by single arrow). After perfusion with verapamil (1 gmol/L), 100 nmol/L angiotensin 11 (All) is supposedly capable of elevating [Ca2 ]' in vascular smooth muscle cells or fibroblasts, because these cells have inositol trisphosphate-sensitive Ca2l stores. However, we did not observe any cells in which [Ca2+J was increased after All exposure (C). Intracellular Ca>' transients during perfusion with verapamil and All confirmed these observations (representative tracings, E). We also tested bradykinin (BK) in place of All, and 1 pmol/L BK after pretreatment with verapamil (1 gmol/L) did not increase [Ca2+1, in any cells (D). Intracellular Ca2+ transients during perfusion with verapamil and BK exhibited identical results (representative tracings, F). In this regard, our primary culture of chick ventricular cells consisted mostly of cardiac myocytes and contained a negligible amount of contaminated nonmyocytes.
activation of NO-cGMP pathways could cause a negative chronotropism. End-diastolic cell position markedly shifted downward (-63.7±4.4%, P<.01, n-3), suggesting that NO produced by inducible NOS may also have decreased Ca> sensitivity of the contractile apparatus. Representative tracings are shown in Fig 8A. In contrast, at the time of 6-hour exposure to IL-6, L-arginine did not induce any significant changes in peak systolic [Ca"I] (99.3±2.9% of the L-NMMA-pretreated control value, n=4) or the amplitude of cell contraction (100.9+3.5% of the L-NMMA-pretreated control value, n=4) in the L-NMMA4pretreated cells, as shown in Fig 8B. These data suggest that IL-6 induced NOS after 24 hours, not 6 hours, which was coincident with the time-dependent changes in cGMP content, and that the induced NOS may have caused both negative inotropic and [Ca2+]i-lowering effects.
Discussion
In the present study, we demonstrated that IL-6 acutely decreased peak systolic [Ca2]i and simultaneously exerted a negative inotropic effect in cultured chick ventricular myocytes. To the best of our knowledge, this is the first report that has shown the [Ca ]2- Exposure Time lowering effect of IL-6. We showed that these acute effects might be mediated by the NO-cGMP pathway and that IL-6 might transiently enhance the constitutive NOS. Furthermore, IL-6 seems to have induced Ca2'independent NOS, and the inducible NOS appears to have also caused decreases in peak systolic [Ca"2]i and the amplitude of cell contraction.
IL-6 of >500 U/mL caused significant effects on cardiac myocytes, as demonstrated in the present study. Compared with effective doses in other types of cells,6 this concentration seems to be relatively high. However, Finkel et a110 reported that IL-6 of >900 U/mL caused significant effects on papillary muscle preparations. The expression levels of IL-6 receptors have been reported to be extremely low in heart, though abundant in liver or lymphocytic cells.34 Therefore, it seems pertinent that a relatively high concentration of IL-6 is required to manifest significant effects on cardiac myocytes.
A couple of reports have shown that cytokines, such as interleukin-l,B or tumor necrosis factor-a, have negative inotropic effects on the isolated perfused heart,35 papillary muscle preparation,10 and cultured rat myocytes. 36 Although intracellular signaling pathways responsible for the cytokine-induced inotropism remain to be elucidated, these pathways may be in part mediated by NO.10,36 These reports support the present study that The initial increase in cGMP was identified at 5, 15 (n=2), and 30 minutes after exposure to 1000 U/mL IL-6, and the delayed increase was observed after 24 hours. No significant increases were observed after 2 minutes (n=3), 1 hour, 2 hours (n=2), or IL-6 (unit/mi) the myocardial depression caused by IL-6 may result from the enhanced production of NO. NO-mediated pathways are multiple,15-18 and two major ones are considered to be responsible for the IL-6-induced effects. One is a cGMP-mediated pathway. In two previous reports,3738 cGMP was shown to have a negative inotropic effect on myocardial cells. Furthermore, it has recently been demonstrated that cGMP decreases L-type Ca2+ current, presumably via cGMP-dependent protein kinase activation in cardiac myocytes. 39 Therefore, the [Ca2+]i-lowering effect of IL-6 may be a consequence of the inhibition of the L-type Ca2' channel through cGMP-dependent protein kinase activation induced by the increased cGMP. cGMP assay confirmed that IL-6 rapidly and transiently increased the content of cGMP in chick ventricular myocytes. This initial increase in cGMP may be coincident with the [Ca2+]i-lowering effect and negative inotropism of IL-6.
The other possible NO-mediated pathway is one through the redox form of NO, which causes cytotoxic effects. 16 In contrast to the cGMP-mediated effects, roles of the redox form of NO in the depressive effect of IL-6 remain to be studied. However, even after 24 hours of exposure to IL-6, no remarkable cytotoxic effect on viability of cultured myocytes was observed by the light-microscopic examination.
A recent work has shown that a negative chronotropism coupled with muscarinic receptors is mediated by NO in spontaneously beating cultured cardiomyocytes. 40 As shown in the present study, perfusion with L-arginine of L-NMMA-pretreated cells after 24 hours of exposure to IL-6 tended to decrease the spontaneous beating rate, suggesting that endogenous NO can cause a negative chronotropism. In contrast, spontaneous beating became faster after exposure to IL-6 even after pretreatment with L-NMMA or methylene blue, although cardiac effects of IL-6 appeared to be mediated by NO. This finding suggests that IL-6 causes a positive chronotropism, possibly via its specific receptors, independent of NO-cGMP pathways and that this positive chronotropism may mask the negative chronotropism coupled with NO-cGMP pathways.
The origin of NO may be one of the most controversial points in the present study. Recently, several isoforms of NOS cDNAs have been cloned,1922,23 but it is still unknown whether any isoforms of NOS are expressed in cardiomyocytes. It is possible that the myocardial effects of IL-6 are mediated by ECNOS in coexisting endothelial cells among our primary culture of cardiomyocytes. However, in the study of Finkel et al10 chemical denuding of endocardial endothelial cells did not reverse the negative inotropic response to IL-6. Furthermore, we have shown by two-dimensional image analyses that our primary culture of chick ventricular cells consists mostly of cardiac myocytes and contains no functionally active endothelial cells. Thus, we prefer an autocrine effect of "cardiac NOS" rather than a paracrine effect of ECNOS in the response to IL-6, although further studies are needed to characterize and localize the NOS isoforms that are responsible for the myocardial effects of IL-6.
According to the cGMP assay, the initial and delayed enhancement of cGMP was induced by IL-6, suggesting a biphasic enhancement of NOS. The initial increase may be coincident with the negative inotropic effect of IL-6 described above. This initial increase in cGMP was inhibited by L-NMMA, suggesting that this cGMP increase was mediated by the enhancement of NOS in cardiac myocytes. The existence of constitutive NOS has been shown in cultured myocytes and is considered to regulate baseline levels of NO production in these cells. 40, 41 Intracellular signaling pathways between the IL-6 receptors and cardiac constitutive NOS are still unclear, but the rapid onset of enhancement may suggest that the initial increase in cGMP results from the activation of the constitutive NOS, not from the induction of the inducible NOS. In noncardiac cells, such as endothelial cells and neuronal cells, activation of the Ca'+-dependent constitutive NOS is mediated by an increase in [Ca2+]". 15, 17, 22, 23 In contrast, the cardiacconstitutive NOS may not be coupled with an increase in [Ca2+]i, because a decrease in [Ca2+]i was actually observed in the present study. In neuronal cells, maximal activation of BNOS was observed at >300 nmol/L free Ca2+, and no significant activation was detectable at <100 nmol/L free Ca2±.42 [Ca 2+]1 of beating cardiomyocytes is cyclically changing within the range of 200 to 700 nmol/L, and then it seems that beating cardiocytes can attain the [Ca2]i levels sufficiently high for activation of the constitutive type of NOS. Therefore, we hypothesize that cardiac myocytes may be desensitized to Ca2' and that direct activation of protein kinases may act mainly in intracellular signaling pathways. However, this cardiac-constitutive NOS was also significantly inhibited by pretreatment with EGTA, which decreased [Ca 2+]i to <100 nmol/L. This implies that the cardiacconstitutive NOS is also a Ca2'-dependent enzyme.
The delayed increase in cGMP is considered to be a consequence of the induction of NOS. The induced NOS may be activated independent of Ca2', considering that the delayed increase in cGMP content was not inhibited in the presence of EGTA. It has been shown that Ca2'-independent NOS can be inducible in myocardium, although the time courses of the NOS induction are various among the studies. 3243 We did not observe any increases in cGMP after 6 hours of exposure to IL-6, and a single stimulation by IL-6 may induce NOS in a slower manner than by lipopolysaccharides or other cytokines. Inducible NOS cDNAs have been cloned in several types of cells, and inducible NOS can be activated independent of Ca2+-calmodulin pathways. 19 The intracellular signaling leading to NOS induction by cytokines or lipopolysaccharides is still unclear. Pretreatment with L-NMMA completely inhibited increases in cGMP content after IL-6 exposure, but the addition of L-arginine at the time of 24-hour exposure manifested the existence of inducible NOS. Therefore, NO-cGMP pathways do not seem to be responsible for the induction of NOS. In addition, the delayed increase in cGMP content was not inhibited by pretreatment with EGTA, suggesting that the cardiac-inducible NOS is not only activated but is also induced by IL-6 without Ca2+calmodulin activation. On the other hand, we consistently showed that pretreatment with dexamethasone significantly inhibited the NOS induction by IL-6 in a manner similar to that in previous reports using other stimuli.32,43,44 These results may offer some clues to the regulatory pathways leading to NOS induction by IL-6, although further studies are required.
As described above, we have shown that IL-6 caused both acute and delayed depression of myocardial contractility. Levels of circulating cytokines are demonstrated to be continuously high in endotoxemia, and the superfusion of cytokines may be an appropriate model for endotoxemia. Additionally, the plasma levels of IL-6 have been reported to be >103 U/mL in patients with sepsis.14 Therefore, IL-6 may partly contribute to depressed myocardial contractility in endotoxic shock. One clinical trial showed that L-NMMA was effective in the treatment of septic shock.45 It is possible that L-NMMA inhibits not only the vasodilatory effect of cytokines but also their negative inotropic effect on myocardium, as we have shown in the present study. Because inducible NOS may act as a cardiac depressant, glucocorticoids may have some beneficial effects on the protection of myocardium in endotoxemia, although the treatment with glucocorticoids in septic shock is still controversial.
On the other hand, serum levels of IL-6 in patients with stunned myocardium are generally <100 U/mL, but localized concentration of IL-6, which is produced by infiltrating macrophages or lymphocytes, may be significantly high, though not proven. In stunned myocardium, myocardial contractile depression is sustained for several hours ex vivo and for several days in vivo.12 Therefore, IL-6 may have a substantial role in this condition through the induction of NOS.
Recently, de Belder et a146 revealed that the Ca2+independent NOS was enhanced in dilated cardiomyopathy. Since, as we have shown, IL-6 may induce Ca2`-independent NOS and depress contractility in myocytes, it may be hypothesized that IL-6 is partly responsible for the contractile dysfunction of dilated cardiomyopathy as well as other cytokines.
In conclusion, IL-6 exerts a negative inotropic effect and [Ca2]i-lowering effect through NO-cGMP pathways in cultured chick embryo ventricular myocytes in both the acute and delayed phases. The acute effects of IL-6 may be mediated by the transient enhancement of constitutive NOS in the cardiac myocytes. IL-6 also causes the delayed induction of inducible NOS in cardiocytes, and this effect may contribute to sustained depression of myocardial contractility in various pathological states.
